1995

Lipa Pharmaceuticals was established as a family business in the south-western suburbs of Sydney, Australia

1997

Achieves sales of $6 million

2000

Annual sales reach $26 million
- Construction new manufacturing facility completed
2001

Operations commence at Minto in early 2001
 - Official opening of Lipa Pharmaceuticals facility


2002

 

Sales growth reaches $33 million
- Lipa Pharmaceuticals awarded National Business Bulletin award

 

2003

Lipa Pharmaceuticals awarded Western Sydney Industries Awards:

 - Global Excellence / Most Outstanding Large Business

2004

 - Most Outstanding Import Replacement by a large business

Lipa completes successful IPO and lists on the Australian Stock Exchange

2005
Lipa celebrates 10 years of operations, with quality and customer service as the corneer stone of the business
- Federal Minister for Health & Aging, Honourble Tony Abbott, officially opens the Lipa Parmaceuticals facilty expansion and new soft gelatin plant.
- Mr Thomas McDonald is appointed as Chief Financial Officer.

2006 Lipa commences production of Soft Gelatin capsules in it's new purpose built high technology facility
Lipa Pharmaceuticals is awarded Western Sydney Industries Award for:
 - Global excellence for most outstanding large business, high commendation
 - Outstanding Innovative Technology - Finalist, large business section
2007
Annual sales reach A$78 million
- Based on successful inplementation of Soft Gelatin facilty, Lipa purchases two additional production lines in order to further increase production capacities.
- Mr Dusko Pejnovic is appointed as Chief Executive Officer.
- November 6, Lipa is acquired by CK Life Sciences Int'l Inc, a public company listed on the Hong kong Stock Exchange.

2008 Business growth continues for Australia's leading contract manufacturer of Innovative Pharmaceutical products
- CK Life Sciences releases 2007 Financial results including revenue of HK$2.1 billion
 www.ck-lifesciences.com